The government has announced it has helped companies secure deals across the globe, including British AI and mobile technology company Medopad.
In May, the London-based company signed two new deals with healthcare organisations in Singapore and Bahamas, creating 100 jobs in Britain.
The Department for International Trade (DIT) provided advice and guidance on technical, financing and contracting issues.
Chief executive of Medopad, Dan Vahdat, said the guidance from DIT helped the firm, which specialises in patient monitoring apps and data analytics, secure “crucial meetings”.
DIT also supported Medopad on the Prime Minister’s business delegation to China earlier this year, where the company signed over £100m worth of deals.
DIT’s global network has since provided assistance, through introductions and market access advice, which gave Medopad the opportunity to successfully win a contract with Singapore’s Agency for Science, Technology and Research (A*STAR).
The agreement will see the company jointly develop a monitoring tool to better manage diabetes for 400,000 sufferers.
Vahdat said: “Managing population health is one of the greatest challenges for governments across the world.
“We are proud to be partnering with a number of countries and being at the forefront of solving this problem and supporting people around the world.”
Medopad is not just making waves across China as in January, the company signed a Memorandum of Understanding (MoU) with the US’s Johns Hopkins University to explore new healthcare solutions using machine learning and patient monitoring technologies.
Another company to have benefited from assistance from DIT is TusPark, the science park development body of Tsinghua University in Beijing, which has invested £8m to set up an innovation centre in Newcastle.
The company recently invested £200m in five new buildings at Cambridge Science Park, directly creating 14 jobs and providing companies with the opportunity to create thousands more in the process.
The Science Park will include a state-of-the-art ‘biohub’, which will provide labs and office space for companies working on innovative healthcare products and technologies.